201 related articles for article (PubMed ID: 21801400)
1. Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
Dow GS; Gettayacamin M; Hansukjariya P; Imerbsin R; Komcharoen S; Sattabongkot J; Kyle D; Milhous W; Cozens S; Kenworthy D; Miller A; Veazey J; Ohrt C
Malar J; 2011 Jul; 10():212. PubMed ID: 21801400
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
3. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Sharma R; Sharma H; Jones S; Borghini-Fuhrer I; Domingo GJ; Gibson RA; Rolfe K; Tan L; Fiţa IG; Chen C; Bird P; Pingle A; Duparc S
Malar J; 2024 May; 23(1):145. PubMed ID: 38741094
[TBL] [Abstract][Full Text] [Related]
4. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L
J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503
[TBL] [Abstract][Full Text] [Related]
5. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
Bassat Q
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1325. PubMed ID: 22216359
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
Staehli Hodel EM; Guidi M; Zanolari B; Mercier T; Duong S; Kabanywanyi AM; Ariey F; Buclin T; Beck HP; Decosterd LA; Olliaro P; Genton B; Csajka C
Malar J; 2013 Jul; 12():235. PubMed ID: 23841950
[TBL] [Abstract][Full Text] [Related]
7. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
[TBL] [Abstract][Full Text] [Related]
8. Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys.
Puri SK; Dutta GP
Acta Trop; 2003 Apr; 86(1):35-40. PubMed ID: 12711101
[TBL] [Abstract][Full Text] [Related]
9. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
[TBL] [Abstract][Full Text] [Related]
10. Artemether-lumefantrine for uncomplicated malaria: a systematic review.
Omari AA; Gamble C; Garner P
Trop Med Int Health; 2004 Feb; 9(2):192-9. PubMed ID: 15040555
[TBL] [Abstract][Full Text] [Related]
11. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.
Lefèvre G; Bhad P; Jain JP; Kalluri S; Cheng Y; Dave H; Stein DS
Malar J; 2013 Sep; 12():312. PubMed ID: 24010572
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacies of quinine and chloroquine as companions to primaquine in a curative drug regimen.
Schmidt LH
Am J Trop Med Hyg; 1981 Jan; 30(1):20-5. PubMed ID: 7212167
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin for treating uncomplicated malaria.
van Eijk AM; Terlouw DJ
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286
[TBL] [Abstract][Full Text] [Related]
15. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
17. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana.
Eibach D; Ceron N; Krishnalall K; Carter K; Bonnot G; Bienvenu AL; Picot S
Malar J; 2012 Oct; 11():347. PubMed ID: 23083017
[TBL] [Abstract][Full Text] [Related]
19. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
[TBL] [Abstract][Full Text] [Related]
20. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rodrigo C; Rajapakse S; Fernando D
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
